Amalgamated Bank Athersys, Inc Transaction History

Amalgamated Bank

  • $12.1 Billion
  • Q3 2024

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.18 - $0.86 $5,802 - $27,721
-32,234 Closed
0 $0
Q1 2022

Jun 30, 2022
SELL
$0.6 - $1.06 $1,543 - $2,727
-2,573 Reduced 7.39%
32,234 $20,000
Q4 2021

Feb 15, 2022
SELL
$0.85 - $1.4 $654 - $1,078
-770 Reduced 2.16%
34,807 $31,000
Q3 2021

Oct 29, 2021
SELL
$1.33 - $1.77 $1,371 - $1,824
-1,031 Reduced 2.82%
35,577 $47,000
Q2 2021

Aug 16, 2021
BUY
$1.41 - $1.94 $13,661 - $18,796
9,689 Added 35.99%
36,608 $53,000
Q4 2020

Feb 12, 2021
BUY
$1.55 - $2.24 $117 - $170
76 Added 0.28%
26,919 $47,000
Q3 2020

Oct 30, 2020
SELL
$1.91 - $3.08 $1,060 - $1,709
-555 Reduced 2.03%
26,843 $52,000
Q2 2020

Aug 10, 2020
BUY
$1.97 - $3.98 $7,133 - $14,411
3,621 Added 15.23%
27,398 $76,000
Q1 2020

May 13, 2020
BUY
$1.17 - $3.0 $4,405 - $11,295
3,765 Added 18.81%
23,777 $71,000
Q3 2019

Nov 13, 2019
SELL
$1.21 - $1.65 $240 - $328
-199 Reduced 0.98%
20,012 $27,000
Q2 2019

Aug 14, 2019
BUY
$1.39 - $2.03 $3,584 - $5,235
2,579 Added 14.63%
20,211 $34,000
Q1 2019

May 15, 2019
BUY
$1.39 - $1.71 $786 - $967
566 Added 3.32%
17,632 $26,000
Q4 2018

Feb 15, 2019
BUY
$1.41 - $2.16 $24,063 - $36,862
17,066 New
17,066 $25,000
Q3 2018

Nov 14, 2018
SELL
$1.86 - $2.18 $32,352 - $37,918
-17,394 Closed
0 $0
Q2 2018

Jul 18, 2018
BUY
$1.76 - $2.79 $6,149 - $9,748
3,494 Added 25.14%
17,394 $34,000
Q1 2018

May 22, 2018
BUY
$1.34 - $2.03 $97 - $148
73 Added 0.53%
13,900 $25,000
Q4 2017

Feb 13, 2018
BUY
$1.65 - $2.45 $1,120 - $1,663
679 Added 5.16%
13,827 $25,000
Q3 2017

Nov 09, 2017
BUY
$1.5 - $2.55 $19,722 - $33,527
13,148
13,148 $27,000

About ATHERSYS, INC

ATHX Quotes by TradingView
  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email